100 Cummings Center
About BioVieBioVie Inc. is a clinical-stage company pursuing the discovery, development, and commercialization of innovative drug therapies for liver disease. The Company is currently focused on developing and commercializing BIV201, a novel approach to the treatment of ascites due to chronic liver cirrhosis.
CEO: Jonathan Adams
CSO: Penelope Markham
Currently, there are no jobs for this employer on BioSpace.
Browse jobs with BioSpace Featured Employers here.